Trimethoprim-Sulfamethoxazole-associated Fulminant Respiratory Failure in Children and Young Adults

Am J Respir Crit Care Med. 2021 Apr 1;203(7):918-921. doi: 10.1164/rccm.202009-3421LE.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Infections / drug therapy*
  • Child
  • Female
  • Humans
  • Male
  • Respiratory Insufficiency / chemically induced*
  • Respiratory Insufficiency / mortality*
  • Respiratory Insufficiency / therapy*
  • Trimethoprim, Sulfamethoxazole Drug Combination / adverse effects*
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use*
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination